Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study

Nikhil V. Kotha,Joel M. Baumgartner,Jula Veerapong,Jordan M. Cloyd,Ahmed Ahmed,Travis E. Grotz,Jennifer L. Leiting,Keith Francis Fournier,Andrew J. Lee,Sean P. Dineen,Sophie Dessureault,Callisia N. Clarke,Harveshp Mogal,Mohammad Y. Zaidi,Maria C. Russell,Sameer H. Patel,Jeffrey J. Sussman,Vikrom K. Dhar,Laura A. Lambert,Ryan J. Hendrix,Daniel E. Abbott,Courtney Pokrzywa,Kelly Lafaro,Byrne Lee,Jonathan B. Greer,Nadege Fackche,Andrew M. Lowy,Kaitlyn J. Kelly

Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study

2019

Introduction The clinical relevance of primary tumor sidedness is not fully understood in colon cancer patients with peritoneal metastasis treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Keywords:

Hyperthermic intraperitoneal chemotherapy
Primary tumor
Colorectal cancer
Medicine
Surgery
Peritoneal Cancer Index
Surgical oncology
Hazard ratio
Gastroenterology
Retrospective cohort study
General surgery
Conventional PCI
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations